Thanks @Nightsong
Some comments
Some comments
If a patient has depression or something else, the guideline should refer to the relevant guideline. There is no need to explain how to manage depression in an ME/CFS guideline. What is important is to acknowledge the difficulty of living with the condition, and to encourage health professionals to provide practical support make life easier.It is recommended that the guideline provide statements about managing additional comorbidities that may be experienced by patients, including mental illness in the context of ME/CFS.
First I've heard of 'quaternary prevention'. I made a similar point in my response to the NHMRC survey regarding quack treatments. The problem is that many doctors don't realise just how much is poorly evidenced, ineffective and potentially harmful.The guideline may consider covering quaternary prevention – the avoidance of harm from medical interventions and medical advice.
Medical interventions might include the use of unapproved, poorly evidenced or low value therapeutics. These interventions may cause direct harm, harm through lost opportunities for better interventions, costs, inequity of access, and negative impacts on the health system.
Whilst patient choice is also important, it is equally important that patients are fully informed about the best available evidence-based care, including which treatments are still experimental, and those that should be avoided or which represent low value care.
Case in point (the poorly evidenced, ineffective and potentially harmful) - exercise interventions. That section is basically a rewording of the HANDI guideline on exercise therapies for CFS. I am constantly amazed that people who should know better don't. Perhaps they don't bother to look at the actual studies and just assume the HANDI Guideline can't be wrong.Exercise interventions
The debate between those that support incrementally increasing physical activity and those that support staying well within an energy envelope requires a dispassionate examination of trial evidence, particularly the multiple long-Covid trials (388 registered trials)viii that are emerging and are likely to provide additional evidence in the near future.
Surveys by patient groups of their members have suggest that incremental physical activity may be harmful to some people with ME/CFS and advocate against such programs. It is possible that these experiences may be due to inappropriately planned or progressed exercise programs, possibly undertaken independently or under supervision from a person without appropriate experience, or subgroups within the spectrum of ME/CFS who are more vulnerable to more severe post-exertional malaise.
It will be important that implementation of any treatment involving an increase in physical activity is very sensitive to these concerns and the guideline must raise awareness that many patients and carers will be aware of the strong advocacy specifically against such programs. Trust and acknowledgement of these concerns, with appropriate caution will necessarily be a crucial part of guideline recommendations.